TAK-960

TAK-960 · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-960, covering 2014-03-03 to 2014-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies [Phase 1]